
|Articles|July 1, 2003
IOL edge design helps to reduce capsulotomy rates at 1 year
Author(s)Cheryl Guttman
San Francisco-The Sensar IOL (AMO) with OptiEdge provides patients with excellent visual acuity, and after 1 year, it is associated with a higher incidence of clear posterior capsules and a lower rate of Nd:YAG capsulotomy compared with the parent model without OptiEdge, reported William J. Fishkind, MD, at the American Society of Cataract and Refractive Surgery annual meeting.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA update: Outlook Therapeutics receives CRL for resubmitted ONS-5010 BLA
2
Innovations in glaucoma poised for breakthrough in 2026 (and what might hold them back)
3
FDA approvals in 2025: What changed and why it matters for ophthalmologists
4
PRIMAvera study: Central vision improvement with subretinal implant
5












































